Global Phage Therapy Market 2024-2028

Description

List of Tables

The phage therapy market is forecasted to grow by USD 51 mn during 2023-2028, accelerating at a CAGR of 17.41% during the forecast period. The report on the phage therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by benefits of phage therapy over antibiotics, increasing application of phage therapy for animal health, and increasing application of phage therapy for human health.

Technavio's phage therapy market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	14.43%
CAGR	17.41%
Incremental Value	$51mn

By Product

Escherichia coli
Staphylococcus aureus
Salmonella
Others

By Application

Animal health
Food industry
Others

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the increasing investments in phage therapy as one of the prime reasons driving the phage therapy market growth during the next few years. Also, increasing clinical trials for phage therapy and increasing number of partnerships among vendors will lead to sizable demand in the market.

The report on the phage therapy market covers the following areas:

Phage therapy market sizing
Phage therapy market forecast
Phage therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phage therapy market vendors that include Adaptive Phage Therapeutics, APS Biocontrol Ltd., Armata Pharmaceuticals Inc., Astellas Pharma Inc., BiomX Inc., CJ CheilJedang Corp., Cytophage Technologies Inc., Eliava Biopreparation LLC, Intralytix Inc., iNtRON Biotechnology Inc., JSC NPO Microgen, Locus Biosciences Inc., Micreos, Micromir, Nexabiome, Proteon Pharmaceuticals S.A., Taconic Biosciences Inc., TechnoPhage, ZeptoMetrix LLC, and Vitalis Wellness LLP. Also, the phage therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77397

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global phage therapy market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global phage therapy market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Escherichia coli - Market size and forecast 2023-2028
Exhibit 34: Chart on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Escherichia coli - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Escherichia coli - Year-over-year growth 2023-2028 (%)
6.4 Staphylococcus aureus - Market size and forecast 2023-2028
Exhibit 38: Chart on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
6.5 Salmonella - Market size and forecast 2023-2028
Exhibit 42: Chart on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Salmonella - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Salmonella - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 52: Chart on Application - Market share 2023-2028 (%)
Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
7.3 Animal health - Market size and forecast 2023-2028
Exhibit 56: Chart on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Animal health - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Animal health - Year-over-year growth 2023-2028 (%)
7.4 Food industry - Market size and forecast 2023-2028
Exhibit 60: Chart on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Food industry - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Food industry - Year-over-year growth 2023-2028 (%)
7.5 Aquaculture and others - Market size and forecast 2023-2028
Exhibit 64: Chart on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Aquaculture and others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Aquaculture and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Application
Exhibit 68: Market opportunity by Application ($ million)
Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Poland - Market size and forecast 2023-2028
Exhibit 99: Chart on Poland - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Poland - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Poland - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Adaptive Phage Therapeutics
Exhibit 119: Adaptive Phage Therapeutics - Overview
Exhibit 120: Adaptive Phage Therapeutics - Product / Service
Exhibit 121: Adaptive Phage Therapeutics - Key offerings
12.4 APS Biocontrol Ltd.
Exhibit 122: APS Biocontrol Ltd. - Overview
Exhibit 123: APS Biocontrol Ltd. - Product / Service
Exhibit 124: APS Biocontrol Ltd. - Key offerings
12.5 Armata Pharmaceuticals Inc.
Exhibit 125: Armata Pharmaceuticals Inc. - Overview
Exhibit 126: Armata Pharmaceuticals Inc. - Product / Service
Exhibit 127: Armata Pharmaceuticals Inc. - Key offerings
12.6 CJ CheilJedang Corp.
Exhibit 128: CJ CheilJedang Corp. - Overview
Exhibit 129: CJ CheilJedang Corp. - Business segments
Exhibit 130: CJ CheilJedang Corp. - Key offerings
Exhibit 131: CJ CheilJedang Corp. - Segment focus
12.7 Cytophage Technologies Inc.
Exhibit 132: Cytophage Technologies Inc. - Overview
Exhibit 133: Cytophage Technologies Inc. - Product / Service
Exhibit 134: Cytophage Technologies Inc. - Key offerings
12.8 Intralytix Inc.
Exhibit 135: Intralytix Inc. - Overview
Exhibit 136: Intralytix Inc. - Product / Service
Exhibit 137: Intralytix Inc. - Key offerings
12.9 iNtRON Biotechnology Inc.
Exhibit 138: iNtRON Biotechnology Inc. - Overview
Exhibit 139: iNtRON Biotechnology Inc. - Product / Service
Exhibit 140: iNtRON Biotechnology Inc. - Key offerings
12.10 JSC NPO Microgen
Exhibit 141: JSC NPO Microgen - Overview
Exhibit 142: JSC NPO Microgen - Product / Service
Exhibit 143: JSC NPO Microgen - Key offerings
12.11 Locus Biosciences Inc.
Exhibit 144: Locus Biosciences Inc. - Overview
Exhibit 145: Locus Biosciences Inc. - Product / Service
Exhibit 146: Locus Biosciences Inc. - Key offerings
12.12 Micreos
Exhibit 147: Micreos - Overview
Exhibit 148: Micreos - Product / Service
Exhibit 149: Micreos - Key offerings
12.13 Micromir
Exhibit 150: Micromir - Overview
Exhibit 151: Micromir - Product / Service
Exhibit 152: Micromir - Key offerings
12.14 Nexabiome
Exhibit 153: Nexabiome - Overview
Exhibit 154: Nexabiome - Product / Service
Exhibit 155: Nexabiome - Key offerings
12.15 Proteon Pharmaceuticals S.A.
Exhibit 156: Proteon Pharmaceuticals S.A. - Overview
Exhibit 157: Proteon Pharmaceuticals S.A. - Product / Service
Exhibit 158: Proteon Pharmaceuticals S.A. - Key offerings
12.16 TechnoPhage
Exhibit 159: TechnoPhage - Overview
Exhibit 160: TechnoPhage - Product / Service
Exhibit 161: TechnoPhage - Key offerings
12.17 ZeptoMetrix LLC
Exhibit 162: ZeptoMetrix LLC - Overview
Exhibit 163: ZeptoMetrix LLC - Product / Service
Exhibit 164: ZeptoMetrix LLC - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations